Stock Events

Stock Events

Telomir Pharmaceuticals (TELO) Q2 2025 Earnings

May 14Confirmed

Q4 2024

Q1 2025

Q2 2025

-0.2

-0.16

-0.11

-0.07

Details

Expected EPS

-0.07

Actual EPS

-0.07

Surprise EPS

0

Surprise Percent

+0%

Description

⁨Telomir Pharmaceuticals⁩ (⁦TELO⁩) has reported earnings of ⁦-0.07⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.